Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLN.L Regulatory News (SLN)

  • There is currently no data for SLN

Form 8.5 (EPT/NON-RI)

13 Sep 2010 13:45

RNS Number : 5814S
Nomura Code Securities Limited
13 September 2010
 



FORM 8.5 (EPT/NON-RI)

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Nomura Code Securities Ltd

(b) Name of offeree in relation to whose relevant securities this form relates:

Silence Therapeutics Ltd

(c) Name of the party to the offer with which exempt principal trader is connected:

Silence Therapeutics Ltd

(d) Date dealing undertaken:

10 Sep 2010

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

 

NO

 

 

2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

0

0.0

563,377

0.2

(2) Derivatives (other than options):

0

(3) Options and agreements to purchase/sell:

0

 

TOTAL:

0

0.0

563,377

0.2

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

None

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

Ord shares

Purchase

35,000

11.5 p

Total

Purchases:

35,000

Ord shares

Sale

428,449

11.67 p

Total

Sales:

428,449

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

No

 

 

Date of disclosure:

13 Sep 2010

Contact name:

Niall Campbell

Telephone number:

020 7776 1226

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FEOUOSURRSAKAAR
Date   Source Headline
3rd Apr 20079:41 amPRNDirector/PDMR Shareholding
30th Mar 20077:10 amPRNNotice of EGM
30th Mar 20077:00 amPRNPreliminary Final Results
16th Mar 20077:00 amPRNResearch Update
28th Feb 20074:23 pmPRNHolding(s) in Company
22nd Feb 20071:01 pmPRNHolding(s) in Company
21st Feb 20077:30 amPRNHolding(s) in Company
21st Feb 20077:00 amPRNResearch Update
9th Feb 200711:13 amPRNHolding(s) in Company
5th Feb 20077:00 amPRNResearch Update
30th Jan 20077:00 amPRNResearch Update
19th Jan 20073:05 pmPRNHolding(s) in Company
3rd Jan 20077:30 amPRNResearch Update
15th Dec 200611:10 amPRNTotal Voting Rights
11th Dec 20067:02 amRNSNobel Prize Congratulations
8th Dec 200611:40 amPRNHolding(s) in Company
6th Dec 200611:45 amPRNHolding(s) in Company
5th Dec 200611:10 amPRNHolding(s) in Company
29th Nov 20067:00 amPRNResearch Update
27th Nov 200610:56 amPRNDirector/PDMR Shareholding
23rd Nov 200610:15 amPRNIssue of Equity
4th Oct 200611:56 amPRNHolding(s) in Company
27th Sep 20063:55 pmPRNHolding(s) in Company
26th Sep 200610:00 amPRNRe Agreement
13th Sep 20068:30 amPRNResearch Update
1st Sep 200612:53 pmPRNHolding(s) in Company
24th Aug 20067:00 amPRNHolding(s) in Company
23rd Jun 20063:15 pmPRNResearch Update
23rd Jun 20067:30 amPRNFinal Results
15th Jun 200612:00 pmPRNResearch Update
6th Jun 20067:00 amPRNResearch Update
3rd May 20065:05 pmPRNIssue of Equity
24th Apr 200611:15 amPRNResearch Update
28th Mar 200612:40 pmPRNLicence agreement signed
20th Dec 200511:36 amPRNIssue of Equity
28th Sep 20056:30 amPRNInterim Results
27th Sep 200510:10 amPRNNotice of Results
21st Sep 20052:30 pmPRNIssue of Equity
1st Aug 200511:01 amPRNAdditional Listing
28th Jul 20056:31 amPRNHoldings in Company, Change of Broker
28th Jul 20056:30 amPRNResult of Equity Issue
12th Jul 20053:06 pmPRNHolding(s) in Company
11th Jul 200512:12 pmPRNResult of EGM
30th Jun 20059:43 amPRNAGM Statement
24th Jun 20054:41 pmRNSSchedule 1 - SR Pharma PLC
24th Jun 20052:30 pmRNSRestoration - SR Pharma PLC
24th Jun 20051:30 pmPRNPublication of Circular to Shareholders
21st Jun 20057:45 amRNSSuspension - SR Pharma PLC
21st Jun 20056:45 amPRNAcquisition(s)
9th Jun 20054:45 pmPRNNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.